Document Detail


Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients.
MedLine Citation:
PMID:  19027898     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The purpose of this prospective randomised clinical study was to compare the efficacy of recombinant bone morphogenetic protein 7 (rhBMP-7) and platelet-rich plasma (PRP) as bone-stimulating agents in the treatment of persistent fracture non-unions. One hundred and twenty patients were randomised into two treatment groups (group rhBMP-7 vs. group PRP). Sixty patients with sixty fracture non-unions were assigned to each group (median age: 44 years, range 19-65, for the rhBMP-7 group and 41 years, range 21-62, for the PRP group, respectively). In the rhBMP-7 group, there were 15 tibial non-unions, 10 femoral, 15 humeral, 12 ulnar, and 8 radial non-unions. In the PRP group, there were 19 tibial non-unions, 8 femoral, 16 humeral, 8 ulnar, and 9 radial non-unions. The median number of operations performed prior to our intervention was 2 (range 1-5) and 2 (range 1-5) with autologous bone graft being used in 23 and 21 cases for the rhBMP-7 and PRP groups, respectively. Both clinical and radiological union occurred in 52 (86.7%) cases of the rhBMP-7 group compared to 41 (68.3%) cases of the PRP group, with a lower median clinical and radiographic healing time observed in the rhBMP-7 group (3.5 months vs. 4 months and 8 months vs. 9 months, respectively). This study supports the view that in the treatment of persistent long bone non-unions, the application of rhBMP-7 as a bone-stimulating agent is superior compared to that of PRP with regard to their clinical and radiological efficacy.
Authors:
G M Calori; L Tagliabue; L Gala; M d'Imporzano; G Peretti; W Albisetti
Related Documents :
3102188 - Indications of primary osteosynthesis in patients with fractures of long bones of extre...
3356728 - Diaphyseal fractures of the humerus. treatment with prefabricated braces.
9076298 - Ipsilateral femoral neck and shaft fractures.
3508158 - Cerclage wiring in the management of comminuted fractures of the femoral shaft.
7994188 - Normal ranges for bone loss rates.
2895448 - Computer-aided three-dimensional reconstruction and measurement of the vestibular end-o...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial     Date:  2008-11-22
Journal Detail:
Title:  Injury     Volume:  39     ISSN:  1879-0267     ISO Abbreviation:  Injury     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2008-12-02     Completed Date:  2009-07-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0226040     Medline TA:  Injury     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1391-402     Citation Subset:  IM    
Affiliation:
Orthopaedic Institute, G. Pini University of Milan, Milan, Italy. gmc@studiocalori.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Bone Morphogenetic Protein 7 / therapeutic use*
Female
Femoral Fractures / drug therapy,  surgery
Fracture Healing / drug effects
Fractures, Ununited / drug therapy*,  surgery
Humans
Humeral Fractures / drug therapy,  surgery
Male
Middle Aged
Osteogenesis / drug effects*
Platelet-Rich Plasma*
Prospective Studies
Recombinant Proteins / therapeutic use
Tibial Fractures / drug therapy,  surgery
Ulna Fractures / drug therapy,  surgery
Young Adult
Chemical
Reg. No./Substance:
0/BMP7 protein, human; 0/Bone Morphogenetic Protein 7; 0/Recombinant Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fuzzy-model-based hybrid predictive control.
Next Document:  Increasing adiposity in normal ovulatory women affects adipocytokine expression in subcutaneous and ...